The introduction of counterfeit pharmaceutical products into the legitimate supply chain has become a global threat over the past years. To respond to the challenge, SAP and Boehringer Ingelheim are co-innovating to established a blockchain-based system that ensures the unique identification and verification of individual medicine packages. Such a system will enable patients and healthcare professionals to easily perform product verification, while ensuring secure data management along the supply chain.